Evidence map›Paper›PMID 42020355›Full record

ArticleTranslational psychiatry2026

Paving the way for precision treatment of psychiatric symptoms with functional connectivity neurofeedback.

J E Taylor, T Oka, M Murakami, T Motegi, T Yamada, T Kawashima, Y Kobayashi, Y Yoshihara, J Miyata, T Murai and 2 more

Abstract read
In one paragraph

Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

J E Taylor *The Department of Decoded Neurofeedback, Computational Neuroscience Laboratories, Advanced Telecommunications Research Institute International, Kyoto, Japan. jessie.elizabeth.taylor@gmail.com.ORCID http://orcid.org/0000-0001-8225-0019
T Oka *The Department of Decoded Neurofeedback, Computational Neuroscience Laboratories, Advanced Telecommunications Research Institute International, Kyoto, Japan.ORCID http://orcid.org/0000-0002-6403-183X
M MurakamiThe Department of Decoded Neurofeedback, Computational Neuroscience Laboratories, Advanced Telecommunications Research Institute International, Kyoto, Japan.
T MotegiThe Department of Decoded Neurofeedback, Computational Neuroscience Laboratories, Advanced Telecommunications Research Institute International, Kyoto, Japan.
T YamadaThe Department of Decoded Neurofeedback, Computational Neuroscience Laboratories, Advanced Telecommunications Research Institute International, Kyoto, Japan.ORCID http://orcid.org/0000-0001-7342-4101
T KawashimaDepartment of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0002-1439-451X
Y KobayashiDepartment of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0009-0002-6865-5188
Y YoshiharaDepartment of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
J MiyataDepartment of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0003-1803-1975
T MuraiDepartment of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0001-6550-8188
M KawatoThe Department of Decoded Neurofeedback, Computational Neuroscience Laboratories, Advanced Telecommunications Research Institute International, Kyoto, Japan.ORCID http://orcid.org/0000-0001-8185-1197
A CorteseThe Department of Decoded Neurofeedback, Computational Neuroscience Laboratories, Advanced Telecommunications Research Institute International, Kyoto, Japan.ORCID http://orcid.org/0000-0003-4567-0924

Funding

Japan Agency for Medical Research and Development (AMED) JP17dm0107044Japan Agency for Medical Research and Development (AMED) JP18dm0307008Japan Agency for Medical Research and Development (AMED) JP21dm0307008Japan Agency for Medical Research and Development (AMED) JP21dm0307102Japan Agency for Medical Research and Development (AMED) P17dm0107044MEXT | Japan Society for the Promotion of Science (JSPS) 24K22822
6 · The paper itself

Abstract

Treatment for Major Depressive Disorder (MDD) remains relatively homogeneous, despite patients having heterogeneous subsets of symptoms with differing underlying neural aberrations. Demonstrating potential for a more individualised treatment approach, we recently showed that normalisation of a neural network and a corresponding reduction in related symptoms can be achieved using real-time fMRI functional connectivity neurofeedback (FCNef). Specifically, we showed that brooding rumination but not anxiety symptoms decreased as functional connectivity between the dorsolateral prefrontal cortex (DLPFC) and posterior cingulate cortex/precuneus (PCC) normalised with FCNef. However, the robustness of this effect, how localised it is in the brain, and the best parameters for optimising therapeutic outcomes remained unknown. We therefore ran additional participants (final N = 68) in our FCNef protocol. We replicated our original findings and ran new analyses that better highlighted the precision of this effect to rumination symptoms. For the first time we also demonstrated that connectivity between the Executive Control and Default-Mode networks reduced significantly with FCNef. Finally, we manipulated core FCNef parameters between participants and found that the most effective protocol involved consecutive training days with greater external reward. These results highlight the potential of FCNef for precision medicine in psychiatry and underscore the importance of optimising parameters to enhance feasibility of BMI-based clinical interventions.

Indexed as

ConnectomeDorsolateral Prefrontal CortexGyrus CinguliMajor Depressive DisorderNerve NetNeurofeedbackPrecision MedicineRumination, CognitiveAdultDefault Mode NetworkExecutive FunctionFemaleHumansMagnetic Resonance ImagingMaleYoung Adult

Identifiers

PMID42020355
PMCPMC13226648

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.